We take a look at the value of patient data, how it can impact Pharma and to what extent it could benefit the industry.
We caught up with Senior Health Economist Idaira Rodriguez Santana, to find out more about her role as well as her biggest achievements so far!
read more >>For Pride Month 2022, Prime Patient investigate how Pharma can build stronger, more productive relationships with the LGBTQIA+ community
This Pride Month, Prime Patient takes a close look at the health inequity faced by the transgender community, and what we can do about it.
Welcoming our newest IGNITE cohort!
Prime Global 13 June, 2022A very warm welcome to the latest cohort of our entry-level training programme, IGNITE. This marks the seventh round since the programme’s inception in 2017, and features trainees across our Medical Communications and Evidence, Access, and Patient practice areas.
read more >>The Corporate Reputation of Pharma in 2021
Prime Global 31 May, 2022This month, the results of the 2021 PatientView corporate reputation survey were released. With insights from 240 US patient groups, a number of key findings were reported; here, we take a closer look.
Not just a buzzword: how Pharma and advocacy leaders are effecting meaningful patient centricity
Prime Global 30 May, 2022On May 24th, the Prime Patient team was fortunate to have a spot at 2022’s Patient Centricity and Engagement Conference, hosted in London, England. With a veritable smorgasbord of topics up for discussion, we were spoiled for choice! Here we summarise some highlights from the day, kicking off with tips on strengthening patient advocacy collaboration.
Evolving applications of omics in healthcare
Prime Global 25 May, 2022Analysis of the molecular landscape that characterises a patient or disease is an evolving area that is increasingly driving discoveries in healthcare.
Haemophilia awareness: building trusted relationships between patients and industry
Prime Global 19 April, 2022Haemophilia is a lifelong genetic disorder characterised by excessive bleeding.(1) Despite the existence of treatments for haemophilia, the condition continues to have major impacts on quality of life, for example in the areas of pain (acute and chronic), joint mobility, and physical function.(1) To mark World Haemophilia Day on 17 April, Prime Patient partnered with sister agency HCD Economics, a consultancy specialising in haemophilia patient research, and haemophilia advocate Laurence Woollard to better understand the existing relationship between patients and industry and how meaningful improvements can be made to the lives of people living with haemophilia (PwH).
Prime Patient team up with Jess Duggan from the SynGAP Research Fund to better understand what this advocacy group wants Pharma to know this Developmental Disabilities Awareness Month.
Prime Patient collaborate with award-winning advocate Trishna Bharadia to explore how industry can better engage with people living with multiple sclerosis (PwMS) this MS Awareness Month.
We caught up with Senior Account Executive Pamela Lopez, to find out more about her role and our Ignite scheme!
read more >>Patient engagement in rare mutation cancers
Prime Global 4 March, 2022Patient advocacy and engagement are important no matter the disease area, whether it’s a common condition or one that few have heard of. Following the recent celebration of Rare Disease Day, let’s take a closer look at patient engagement in rare mutation cancers.
In the spirit of Rare Disease Day, which was celebrated on 28 February, we’re looking at the importance of patient engagement in lysosomal storage disorders (LSDs).
Amplifying the Patient Voice in Rare Diseases
Prime Global 1 March, 2022Medical publishing is evolving beyond plain language summaries to provide insightful, patient-centred resources to change the course of pharmaceutical research for the better. For patients with rare diseases especially, this could be just what the doctor ordered, writes Olivia Kersey, Patient Engagement Strategist with Prime Patient.
Rare reflections: has the pandemic helped or hindered patient engagement and research for rare diseases?
Prime Global 28 February, 2022Emma Sutcliffe, SVP Patient Insights and Solutions, Prime Patient shares her reflections about whether the pandemic has helped or hindered patient engagement and research for rare diseases.
Amplifying the patient voice in healthcare through tech adoption
Prime Global 17 February, 2022We chat with Digital Health Consultant, Barnaby Poulton, about how technology can help amplify the patient voice.
International Day of Women and Girls in Science
Prime Global 11 February, 2022To celebrate International Day of Women and Girls in Science, some of our brilliant women are sharing advice about achieving career goals, how they started their career in medcomms and their experience of being a woman of science.
read more >>Highlights from ISMPP Europe 2022
Prime Global 10 February, 2022This year’s ISMPP Europe meeting was action packed, with Prime Global sending 5 team members, presenting 5 posters, sharing 7 publication extenders, and moderating 2 roundtables! Here, we share some of our key highlights from the conference.
read more >>How to make 2022 the best year yet for patient engagement
Prime Global 31 January, 2022Olivia Kersey, Patient Engagement Strategist, outlines what we can learn from 2021 to optimise patient engagement strategy and implementation in 2022.
While there would be no such thing as the pharmaceutical industry without patients, it’s only in recent years that collaboration with patients has started to enter the mainstream. While 2021 was a good year for patient engagement, 2022 can be both bigger and better.
Patient authorship survey poster presented at ISMPP 2022
Prime Global 26 January, 2022The Prime Patient team are proud to have had a poster accepted for presentation at the 2022 European meeting of ISMPP (International Society for Medical Publication Professionals), held virtually on 25-26 January. The poster, one of five accepted across Prime Global, presents the results of an internal survey that aimed to identify barriers and solutions to working with patient authors in medical publications.
Prime Global acquires HCD Economics, creating an innovative evidence-generating, HEOR, value & communications group
Prime Global 24 January, 2022Prime Global, a recognised global leader in medical communications and market access, has strengthened its Evidence, Access, and Patient Practice with the acquisition of HCD Economics, an academically aligned organisation focusing on health economics and outcomes research (HEOR) and real-world evidence (RWE). HCD will work closely with Prime Global’s highly experienced medical communications agencies and specialist consultancies, including market access consultancy, Prime Access, and patient engagement experts, Prime Patient, to deliver integrated evidence-led services.
read more >>Creating an effective patient engagement set of practices that is enduring and future-proof
Prime Global 23 December, 2021What’s next for different disciplines of patient engagement in 2022? Find out more with Emma Sutcliffe, Jon Hoggard, Olivia K, and Ross Jackson. We are committed to providing Voice to Value practices that are egalitarian and enduring.
People living with HIV: 40 years of patient activism
Prime Global 1 December, 2021This World AIDS Day, Emma Sutcliffe, SVP Patient Insights and Solutions, takes a look at how far we’ve come and how far we’ve yet to go. Patient activism is a key factor in this progression; Emma discusses her experiences over a near-three-decade career in medical communications and working with patient organisations and how central the patient really is.
read more >>
How can we make lung cancer trials more patient-centric?
Prime Global 22 November, 2021In recognition of Lung Cancer Awareness Month, Olivia Kersey, Patient Engagement Strategist, illustrates current opportunities for the pharmaceutical industry to better meet lung cancer patients’ needs across clinical trials and beyond.
read more >>
Your guide to patient authorship
Prime Global 17 November, 2021Patient involvement in clinical trial design has evolved to provide opportunity for patients to be involved in medical publications. This evolution has allowed medical publications to gain invaluable patient perspectives on clinical research, by involving patients as authors in the development of plain language summaries and other, more traditional types of research publications1.
read more >>An interview with Kirsty Anderson, Digital Project Lead
Prime Global 17 November, 2021Kirsty Anderson, Digital Project Lead, took the time to discuss all things digital with us! In this interview, she shares insight into her role, the challenges and opportunities of a digital project, and her views on the future of digital.
read more >>Key Themes from ISMPP West 2021
Prime Global 15 November, 2021We were glad to attend the ISMPP West 2021 Meeting on October 21–22, the first in-person meeting in almost two years! The meeting focused on opportunities for connectivity, transparency, and inclusivity, and Jenny Blackham, VP Client Partnerships, gave us first-hand insight! Read below to learn more about the key themes at the conference.
read more >>Health literacy for the intellectually disabled: is pharma doing enough?
Prime Global 29 October, 2021What is health literacy and why is it important? Olivia Kersey, Patient Strategist, writes in Pharmaphorum’s October Deep Dive